Oncologists Accepting Molina HealthcarePage 5

David Kwiatkowski, MD

Professor of Medicine at Harvard Medical School, and Senior Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. He earned a BSc from Caltec; Senior Physician

Oncology

Jeffrey Clark, MD

Associate Professor, Medicine, Harvard Medical School

Oncology

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Sarah Blair, M.D.

Professor & Vice Chair, Department of Surgery, UC San Diego School of Medicine

Oncology

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Craig Bunnell, MD

Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hos; Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on

Oncology

Justine Cohen, DO

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

John Donahue, MD

Clinician in Radiology and Biomedical Imaging, Yale School of Medicine

Oncology

Haeseong Park, MD

Medical Oncology

Oncology

Lakshmi Nayak, M.D.

Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma

Oncology

Omar Nadeem, M.D.

Senior Physician, Assistant Professor of Medicine at Harvard Medical School

Oncology

Ephraim Hochberg, MD

Oncology

Elad Sharon, M.D.

Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha

Oncology

Wenxin Xu, M.D.

Instructor in Medicine, Genitourinary Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Oncology

William Hahn, MD PHD

Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Ins; Chief Operating and Transformation Officer at the Dana-Farber Cancer Institute.

Oncology

June Hou, M.D.

Associate Professor of Obstetrics & Gynecology at CUMC

Oncology

Leah Biller, MD

Assistant Professor of Medicine at Harvard Medical School and a physician in the Gastrointestinal Cancer Center and the Cancer Genetics and Prevention Center at Dana-Far

Oncology

Lakshmi Rajdev, MD

Associate Professor of Medicine, Hematology and Medical Oncology; Medical Director of Oncology, Mount Sinai Morningside

Oncology

Ross Berkowitz, MD

Professor of Gynecology, Harvard Medical School

Oncology